10-Q: Embrace Change Acquisition Corp. Reports First Quarter 2024 Results Amidst Extension Efforts
Quarterly Report
Embrace Change Acquisition Corp. reported a net income of $307,277 for the first quarter of 2024, while continuing efforts to secure a business combination and extend its operational timeline.
Summary
- Embrace Change Acquisition Corp., a blank check company, released its financial results for the first quarter of 2024, showing a net income of $307,277.
- The company's total assets were $57,271,938, primarily consisting of marketable securities held in a trust account.
- The company has been extending its deadline to complete a business combination, incurring costs and raising funds through convertible promissory notes.
- The company's operating costs for the quarter were $49,800, and they experienced a loss on modification of deferred underwriting commission of $378,501.
- The company has extended its termination date to August 12, 2024, by depositing additional funds into the trust account.
- The company is facing challenges related to Nasdaq listing compliance and has requested a hearing to appeal a delisting determination.
Sentiment
Score: 3
Explanation: The document indicates significant challenges, including a decrease in net income, a working capital deficit, potential delisting from Nasdaq, and reliance on debt financing. The company's future is highly uncertain, leading to a negative sentiment.
Positives
- The company generated a net income of $307,277 for the quarter.
- The company successfully extended its business combination deadline to August 12, 2024.
- The company has a substantial amount of assets held in a trust account, totaling $57,266,630.
Negatives
- The company's net income decreased compared to the same period last year, from $694,054 to $307,277.
- The company incurred a loss on modification of deferred underwriting commission of $378,501.
- The company has a working capital deficit of $1,876,397.
- The company is facing potential delisting from Nasdaq due to non-compliance with listing rules.
- The company has a limited cash balance of $5,308 outside of the trust account.
Risks
- The company's ability to complete a business combination by August 12, 2024, is uncertain.
- The company is facing potential delisting from Nasdaq due to non-compliance with listing rules.
- The company has a working capital deficit and relies on related party loans and convertible notes.
- The company's financial statements include a going concern consideration due to the uncertainty of completing a business combination.
- The company's disclosure controls and procedures were deemed not effective.
Future Outlook
The company is focused on completing a business combination by the extended deadline of August 12, 2024, and is seeking shareholder approval for further extensions. The company's future is dependent on its ability to secure a business combination and maintain its Nasdaq listing.
Management Comments
- Management has determined that if the Company is unsuccessful in consummating an Initial Business Combination by August 12, 2024, the requirement that the Company cease all operations, redeem the Public Shares and thereafter liquidate and dissolve raises substantial doubt about the Company's ability to continue as a going concern.
- Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company's financial position, results of its operations, close of the Offering, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements.
Industry Context
The company operates in the special purpose acquisition company (SPAC) sector, which has seen increased scrutiny and challenges in recent years. The company's struggles to complete a business combination and maintain its listing are reflective of broader trends in the SPAC market, where many companies are facing similar difficulties.
Comparison to Industry Standards
- The company's performance is below the average for SPACs that have successfully completed a business combination, as many of those companies have generated revenue and have a clear path to profitability.
- The company's reliance on related party loans and convertible notes is not uncommon for SPACs in the pre-combination phase, but the level of debt and the uncertainty surrounding the business combination raise concerns.
- The company's challenges with Nasdaq listing compliance are not unique, as many SPACs have faced similar issues due to low trading volume and shareholder redemptions.
- Compared to other SPACs, the company's cash balance outside of the trust account is relatively low, which limits its flexibility in pursuing a business combination.
Related Party Transactions
- The company has borrowed $770,112 under convertible promissory notes, primarily from the company's CFO.
- The company owes $62,260 to a related party for expenses paid on its behalf.
- The company's sponsor provided office space free of charge.
Stakeholder Impact
- Shareholders face the risk of losing their investment if the company fails to complete a business combination.
- The company's employees and management are facing uncertainty about the company's future.
- The company's creditors are exposed to the risk of non-payment if the company liquidates.
Next Steps
- The company needs to complete a business combination by August 12, 2024, or seek further extensions.
- The company needs to regain compliance with Nasdaq listing rules to avoid delisting.
- The company is seeking shareholder approval for an extension of the business combination deadline at a meeting scheduled for August 12, 2024.
Key Dates
| Date | Description |
|---|---|
| 2021-03-03 | Embrace Change Acquisition Corp. was incorporated in the Cayman Islands. |
| 2022-08-09 | The registration statement for the company's Initial Public Offering was declared effective. |
| 2022-08-12 | The company consummated its Initial Public Offering and private placement. |
| 2023-08-09 | The company held an extraordinary general meeting of shareholders to approve extension of the business combination period. |
| 2023-08-14 | The company accepted a reversal request for 109,819 shares after the extraordinary general meeting. |
| 2023-10-20 | The company held an annual general meeting of shareholders. |
| 2024-03-04 | The company entered into a satisfaction and discharge agreement with the underwriter. |
| 2024-03-31 | End of the reporting period for the first quarter financial results. |
| 2024-04-23 | The company received a delisting determination letter from Nasdaq. |
| 2024-05-30 | The company received a delinquency notification letter from Nasdaq. |
| 2024-06-24 | The company received a notice from Nasdaq indicating potential suspension and delisting. |
| 2024-07-01 | Deadline for the company to request a hearing before a Nasdaq Hearings Panel. |
| 2024-07-16 | Suspension of the company's securities was stayed until this date. |
| 2024-07-25 | The company received a notice from Nasdaq extending the stay of suspension. |
| 2024-08-01 | The company attended the Nasdaq hearing before the Panel. |
| 2024-08-05 | The company borrowed $300,000 from an unrelated third party. |
| 2024-08-06 | The company deposited $400,000 into the trust account, extending the termination date. |
| 2024-08-07 | Date of the filing of the quarterly report. |
| 2024-08-12 | The company's extended deadline to complete a business combination and date of the shareholders meeting. |
Keywords
SPAC, Business Combination, Initial Public Offering, Trust Account, Redemption, Convertible Promissory Notes, Nasdaq, Delisting, Financial Results, Extension
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.